- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/36 - Oxygen or sulfur atoms
Patent holdings for IPC class C07D 207/36
Total number of patents in this class: 188
10-year publication summary
|
15
|
8
|
21
|
10
|
16
|
15
|
15
|
10
|
12
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2708 |
13 |
| Daewoong Pharmaceutical Co., Ltd. | 317 |
8 |
| Novartis AG | 10883 |
7 |
| Bayer Cropscience AG | 2057 |
7 |
| Syngenta Participations AG | 1912 |
6 |
| Cv6 Therapeutics (NI) Limited | 32 |
5 |
| University of Leicester | 220 |
4 |
| Infex Therapeutics Limited | 17 |
4 |
| Omeros Corporation | 307 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 868 |
3 |
| Vectus Biosystems Limited | 35 |
3 |
| Ascentage Pharma (Suzhou) Co., Ltd. | 175 |
3 |
| Ascentage Pharma Group Corp Limited | 124 |
3 |
| Rewind Therapeutics NV | 4 |
3 |
| F. Hoffmann-La Roche AG | 7923 |
2 |
| Bayer Intellectual Property GmbH | 2519 |
2 |
| Abbvie Inc. | 1803 |
2 |
| University of Florida Research Foundation, Inc. | 3994 |
2 |
| Alere San Diego, Inc. | 64 |
2 |
| The Brigham and Women's Hospital, Inc. | 2174 |
2 |
| Other owners | 104 |